More Articles

Ranbaxy pays US$500 million to resolve US litigation Generics/News | Posted 24/05/2013

In what has been hailed as the largest ever settlement of its kind involving a drug safety settlement with a generics manufacturer, Ranbaxy Laboratories (Ranbaxy) pleaded guilty to violations of th...

Huahai and Oncobiologics make biosimilars deal Biosimilars/News | Posted 24/05/2013

US-based Oncobiologics announced on 8 May 2013 that it had signed an alliance agreement for the development, manufacture and commercialization of biosimilar monoclonal antibodies with Zhejiang Huah...

Sanofi fined for discouraging generic clopidogrel prescriptions Generics/News | Posted 17/05/2013

On 14 May 2013, French drugmaker sanofi-aventis was fined Euros 40.6 million by the French competition authority (L’Autorité de la concurrence) for marketing practices that discouraged sales of gen...

Australia reviews chemotherapy drug subsidies Policies & Legislation | Posted 17/05/2013

The Australian Government announced on 5 May 2013 a major review into the way chemotherapy drugs are funded.

US places India on IP black list Reports | Posted 17/05/2013

The US has placed India on a special trade black list of countries that have raised concerns about intellectual property rights.

Actavis in discussions to buy Warner Chilcott Pharma News | Posted 17/05/2013

US generics maker Actavis (formerly Watson) confirmed on 14 May 2013 that the company had entered into discussions to buy Irish drugmaker Warner Chilcott.

FDA rejects Endo petition to stop Opana ER generics Generics/News | Posted 17/05/2013

On 10 May 2013, FDA announced that it had rejected a petition by Endo Pharmaceuticals (Endo) to stop generics of its powerful painkiller, Opana ER (oxymorphone).

Updated guideline on the use of epoetin and darbepoetin in cancer patients Guidelines | Posted 17/05/2013

Patients undergoing chemotherapy for cancer can often become anaemic as their red blood cell counts, and hence iron levels, fall. Besides the traditional approach of offering blood transfusion in o...